Severe hypotension complicating primary angioplasty: Allergy to abciximab

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 7, 2003, Pages 688-689

  Hawkins, C ^a   Gatenby, P ^a   McGill, D ^a  

^a CANBERRA HOSPITAL   (Australia)

Author keywords

Abciximab; Adverse reaction; Allergy; Anaphylaxis

Indexed keywords

ABCIXIMAB;

ADULT; ANGIONEUROTIC EDEMA; ANGIOPLASTY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ERYTHEMA; HEART INFARCTION; HUMAN; HYPOTENSION; LABORATORY TEST; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; SKIN TEST; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG ERUPTIONS; ERYTHEMA; HUMANS; HYPOTENSION; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; STENTS;

EID: 0037561047     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00190.x     Document Type: Article

References (9)

1. SOYKAN I, ERTAN C, OZDEN A. Severe anaphylactic reaction to infliximab: report of a case. Am J Gastroenterol 2000;95:2395-2396.
2. TAM S, SADDOLI P, JORDAN R, NAKADA M. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha v beta 3 integrins. Circulation 1998;98:1085-1091.
3. THE EPIC INVESTIGATORS. Use of a monclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
4. TCHENG J, KEREIAKES D, BRADEN G, JORDAN R, MASCELLI M, LANGRALL M, EFFRON M. Readministration of abciximab: interim report of the ReoPro readministration registry. Am Heart J 1999;138:S33-S38.
5. TCHENG J, KEREIAKES D, LINCOFF A, GEORGE B, KLEIMAN N, SANE D, CINES D, JORDAN R, MASCELLI M, LANGRALL M, DAMARAJU L, SCHANTZ A, EFFRON M, BRADEN G. Abciximab readministration - Results of the ReoPro readministration registry. Circulation 2001;104:870-875.
6. GUZZO J, NICHOLS T. Possible anaphylactic reaction to abciximab. Cathet Cardiovasc Intervent 1999;48:71-73.
7. MONERET-VAUTRIN D, MORISSET M, VIGNAUD J, KANNY G. T cell mediated allergy to abciximab. Allergy 2002;57:269-270.
8. RING J, BROCKOW K. Mechanisms of pseudo-allergic reactions due to radiographic contrast media. Allergy Clin Immunol Int 1996;8:123-125.
9. PUCHNER T, KUGATHASAN S, KELLY K, BINION D. Successful desensitization and therapeutic use of infliximab in adult and pediatric Crohn's disease patients with prior anaphylactic reaction. Inflammatory Bowel Dis 2001;7:34-37.